Literature DB >> 9412312

Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.

S E McNagny1, N K Wenger, E Frank.   

Abstract

BACKGROUND: Women physicians' use of postmenopausal hormone replacement therapy (HRT) is unknown.
OBJECTIVE: To study use of HRT by women physicians in the United States.
DESIGN: Stratified random-sample mail survey.
SETTING: United States Participants: 1466 postmenopausal women U.S. physicians in the Women Physicians' health study. MEASUREMENTS: Self-reported personal use of HRT and information on demographic, professional, and behavioral characteristics and medical history.
RESULTS: Overall, 47.4% of participants currently use HRT; the prevalence of use is 59.8% in women 40 to 49 years of age, 49.4% in women 50 to 59 years of age, and 36.4% in women 60 to 70 years of age (P < 0.001). In an adjusted logistic regression model, current users were significantly more likely to be gynecologists, to be younger, to be white, to be sexually active, to be previous users of oral contraceptives, to live in Pacific or Mountain states, to have had a hysterectomy, and to have no personal or family history of breast cancer.
CONCLUSIONS: Women physicians have a higher rate of HRT use than that reported in cross-sectional U.S. surveys. This may presage greater use of HRT for U.S. women in the future.

Entities:  

Mesh:

Year:  1997        PMID: 9412312     DOI: 10.7326/0003-4819-127-12-199712150-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  7 in total

Review 1.  Hormone replacement therapy and breast cancer: estimate of risk.

Authors:  Nathan J Coombs; Richard Taylor; Nicholas Wilcken; John Boyages
Journal:  BMJ       Date:  2005-08-06

2.  Hormone replacement therapy.

Authors:  H Winpenny
Journal:  Br J Gen Pract       Date:  1998-05       Impact factor: 5.386

Review 3.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

Authors:  M T Connelly; M Richardson; R Platt
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

5.  Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women.

Authors:  Robert Gramling; Charles B Eaton; Kenneth J Rothman; Howard Cabral; Rebecca A Silliman; Timothy L Lash
Journal:  Epidemiology       Date:  2009-09       Impact factor: 4.822

6.  Ethnic differences in hormone replacement prescribing patterns.

Authors:  A F Brown; E J Pérez-Stable; E E Whitaker; S F Posner; M Alexander; J Gathe; A E Washington
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

7.  Healthcare Service Utilization for Practicing Physicians: A Population-Based Study.

Authors:  Yu-Lung Chiu; Senyong Kao; Herng-Ching Lin; Ming-Chieh Tsai; Cha-Ze Lee
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.